| 47.40 Data as of 4:00pm ET |  +0.40 / +0.85%Today’s Change | 30.64 Today|||52-Week Range 47.55 | +45.44% Year-to-Date |
| Promising Data on ONCY's Reolysin - Analyst Blog 4:34pm / Zacks.com | Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons May 20 / TheStreet.com |
| Oncogenex to Advance OGX-427 Development - Analyst Blog 4:03pm / Zacks.com | 5 Drugs Stocks On The Rise May 20 / TheStreet.com |
| Gilead's Sofosbuvir under European Review - Analyst Blog May 22 / Zacks.com | Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner May 17 / TheStreet.com |
| Bristol-Myers Squibb Reaches New 52-Week High (BMY) May 22 / TheStreet.com | Analysts' Actions: AMAT ARUN BMY DE WSM May 17 / TheStreet.com |
| Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLA May 21 / TheStreet.com | Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog May 15 / Zacks.com |
| Previous close | 47.00 |
| Today’s open | 46.56 |
| Day’s range | 45.81 - 47.55 |
| Volume | 12,605,344 |
| Average volume (3 months) | 10,456,331 |
| Market cap | $77.2B |
| Dividend yield | 2.95% |
| Earnings growth (last year) | -46.30% |
| Earnings growth (this year) | -8.61% |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | -17.05% |
| P/E ratio | 54.5 |
| Price/Sales | 3.09 |
| Price/Book | 5.62 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie Inc | -1.15 | -2.47% |
| NVONovo Nordisk A/S | -0.28 | -0.17% |
| AZNAstraZeneca PLC | +0.09 | +0.17% |
| LLYEli Lilly and Co | -0.60 | -1.10% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $17.6B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 11.12% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Lamberto Andreotti |
Chief Financial Officer & Executive Vice President Charles A. Bancroft, MBA, CPA |
Corporate headquarters New York, New York |
.
